Eric Cantor to Lead PhRMA Amid Rising Pharma Scrutiny
Former House Majority Leader Eric Cantor has been named the next president and CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA), effective November 9. He will succeed Steve Ubl, who is stepping down after 11 years. Cantor, a former Virginia Republican, joins the trade group at a critical time as the pharmaceutical industry faces intense scrutiny over drug pricing, tariffs, and vaccine safety from both the Trump administration and Congress. The appointment marks a shift toward a leader with significant business and political experience, though it has drawn mixed reactions regarding his partisan background.